EWTX
Edgewise TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
EWTX vs peer average
54/100
EWTX vs. peer average (D vs. D)
Grade spread
B 1 · C 1 · D 2 · F 5
Graded peers loaded
Coverage
9 graded
90% of tracked
Peer overview
ORKA is the first available peer comparator.
Oruka is a size-matched clinical-stage biotech, but it is not an indication-matched muscle-disease peer; useful mainly as a risk-capital and development-stage comparison.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
EWTX
Edgewise Therapeutics
ORKA
Oruka Therapeutics
Grade
D
F
Momentum
54
68
Value
41
41
Sentiment
57
0
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs ORKA
EWTX / ORKA
Grade Position
In line
EWTX vs. peer average (D vs. D)
54/100
Momentum
54
ORKAValue
41
EWTXSentiment
57
EWTXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs EWTX
ORKA is the first peer returned for this comparison set.